Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

7.77
Delayed Data
As of Aug 04
 -0.22 / -2.75%
Today’s Change
6.23
Today|||52-Week Range
25.60
-51.56%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Astrazeneca Plc
Sale11/12/20142,000,000$17.00$34.0M-60.40%
Isis Pharmaceuticals Inc
Sale7/16/2015167,000$10.79$1.8M-27.65%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale3/05/201565,614$20.06$1.3M-63.23%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/28/201572,011$17.97$1.3M-56.00%
Gibson Neil W
Chief Scientific Officer
Sale1/28/201571,345$17.98$1.3M-56.00%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/17/201573,929$16.94$1.3M-55.09%
Isis Pharmaceuticals Inc
Sale7/17/2015111,000$10.21$1.1M-24.27%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/20/201566,071$16.85$1.1M-54.77%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/21/201560,000$17.73$1.1M-55.90%
Alnylam Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K-43.49%
Page of 16